{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:07:27Z","timestamp":1789182447138,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Children with Down syndrome (DS) are at increased risk for recurrent and severe respiratory infections. Pneumococcal IgG measurements are used in clinical practice to evaluate humoral immunity, yet their clinical relevance in DS remains unclear. We examined potential associations between pneumococcal IgG concentrations and clinical characteristics in children with DS, including recurrent infections and respiratory hospital admission. We conducted a retrospective study in a paediatric DS cohort with repeated pneumococcal IgG measurements obtained from left-over plasma samples using ELISA and multiplex bead-based (Luminex) assays. Potential associations with selected clinical variables, including respiratory hospital admission, the presence of autoimmune comorbidity, and infections, were assessed using mixed-effects modelling. A cross-sectional analysis using only the last available measurement per participant was performed to address the temporal uncertainty between the static information on the clinical variables and the repeated antibody measurements. Across both assays, a history of hospital admission for respiratory problems was associated with lower pneumococcal IgG concentrations in linear mixed-effect regression analyses; a history of autoimmune comorbidity was associated with higher concentrations. A history of recurrent ear infection was associated with lower ELISA-measured IgG concentrations in the last-timepoint analysis.\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : Our exploratory analysis suggests a potential association between lower pneumococcal IgG concentration and selected clinical characteristics in children with DS. These findings support further investigation into the clinical relevance of pneumococcal antibody measurements in children with DS in larger, prospective studies.\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              <jats:italic>\u2022 Down syndrome is associated with increased respiratory infections<\/jats:italic>\n                              <jats:italic>\u2022 Pneumococcal IgG measurements can be used to assess humoral immune function<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              <jats:italic>\u2022 Lower pneumococcal IgG concentrations were observed in the children with a history of respiratory hospital admission<\/jats:italic>\n                              <jats:italic>\u2022 Higher pneumococcal IgG concentrations were observed in the children with a history of autoimmunity<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-026-07364-w","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:30:10Z","timestamp":1787934610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lower pneumococcal IgG levels and respiratory hospitalisation in children with Down syndrome; an exploratory study"],"prefix":"10.1007","volume":"185","author":[{"given":"Juliette","family":"Krop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noortje B.","family":"Eijsvoogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Murk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco W. J.","family":"Schreurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs Th. J.","family":"van Well","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levinus A.","family":"Bok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"7364_CR1","unstructured":"(WHO\/Europe) (2024)\u00a0WHO Regional Office for Europe.\u00a0European Health for All database (HFA-DB).\u00a0https:\/\/gateway.euro.who.int\/en\/indicators\/hfa_604-7121-number-of-births-with-downs-syndrome\/#id=19699"},{"issue":"2","key":"7364_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2249.2009.03890.x","volume":"156","author":"MA Kusters","year":"2009","unstructured":"Kusters MA et al (2009) Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol 156(2):189\u2013193","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"7364_CR3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.micinf.2010.05.007","volume":"12","author":"BL Bloemers","year":"2010","unstructured":"Bloemers BL et al (2010) Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system. Microbes Infect 12(11):799\u2013808","journal-title":"Microbes Infect"},{"issue":"1","key":"7364_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2249.2011.04335.x","volume":"164","author":"G Ram","year":"2011","unstructured":"Ram G, Chinen J (2011) Infections and immunodeficiency in Down syndrome. Clin Exp Immunol 164(1):9\u201316","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"7364_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/pai.13133","volume":"31","author":"RHJ Verstegen","year":"2020","unstructured":"Verstegen RHJ, Chang KJJ, Kusters MAA (2020) Clinical implications of immune-mediated diseases in children with Down syndrome. Pediatr Allergy Immunol 31(2):117\u2013123","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"7364_CR6","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/ppul.26371","volume":"58","author":"N Arwas","year":"2023","unstructured":"Arwas N et al (2023) Flexible bronchoscopy in pediatric patients with Down syndrome: a case-control study of the indications, findings, and complications. Pediatr Pulmonol 58(6):1658\u20131664","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"7364_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.17294\/2330-0698.1876","volume":"9","author":"V Fitzpatrick","year":"2022","unstructured":"Fitzpatrick V et al (2022) Prevalence of infectious diseases among 6078 individuals with Down syndrome in the United States. J Patient Cent Res Rev 9(1):64\u201369","journal-title":"J Patient Cent Res Rev"},{"issue":"1","key":"7364_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.humimm.2009.09.361","volume":"71","author":"RM Nisihara","year":"2010","unstructured":"Nisihara RM et al (2010) Mannan-binding lectin deficiency increases the risk of recurrent infections in children with Down\u2019s syndrome. Hum Immunol 71(1):63\u201366","journal-title":"Hum Immunol"},{"issue":"2","key":"7364_CR9","first-page":"163","volume":"5","author":"T Patiroglu","year":"2018","unstructured":"Patiroglu T, Cansever M, Bektas F (2018) Underlying factors of recurrent infections in patients with Down syndrome. North Clin Istanb 5(2):163\u2013168","journal-title":"North Clin Istanb"},{"issue":"1","key":"7364_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10238-017-0457-2","volume":"18","author":"AN Seckin","year":"2018","unstructured":"Seckin AN et al (2018) Age-related alterations of the CD19 complex and memory B cells in children with Down syndrome. Clin Exp Med 18(1):125\u2013131","journal-title":"Clin Exp Med"},{"issue":"5","key":"7364_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1203\/PDR.0b013e3181d4ecc1","volume":"67","author":"RH Verstegen","year":"2010","unstructured":"Verstegen RH et al (2010) Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help. Pediatr Res 67(5):563\u2013569","journal-title":"Pediatr Res"},{"issue":"5","key":"7364_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1203\/PDR.0b013e3181d4eca3","volume":"67","author":"MA Kusters","year":"2010","unstructured":"Kusters MA et al (2010) Both normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome T lymphocytes. Pediatr Res 67(5):557\u2013562","journal-title":"Pediatr Res"},{"issue":"6","key":"7364_CR13","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.jaci.2014.07.015","volume":"134","author":"RHJ Verstegen","year":"2014","unstructured":"Verstegen RHJ et al (2014) Defective B-cell memory in patients with Down syndrome. J Allergy Clin Immunol 134(6):1346-1353.e9","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"7364_CR14","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/eji.201445049","volume":"45","author":"R Carsetti","year":"2015","unstructured":"Carsetti R et al (2015) Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome. Eur J Immunol 45(3):903\u2013914","journal-title":"Eur J Immunol"},{"issue":"52","key":"7364_CR15","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.1016\/j.vaccine.2013.09.070","volume":"31","author":"MA Kusters","year":"2013","unstructured":"Kusters MA et al (2013) Functionality of the pneumococcal antibody response in Down syndrome subjects. Vaccine 31(52):6261\u20136265","journal-title":"Vaccine"},{"issue":"12","key":"7364_CR16","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1590\/S0100-879X2006001200010","volume":"39","author":"BT Costa-Carvalho","year":"2006","unstructured":"Costa-Carvalho BT et al (2006) Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients. Braz J Med Biol Res 39(12):1587\u20131592","journal-title":"Braz J Med Biol Res"},{"issue":"9","key":"7364_CR17","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/jmv.24813","volume":"89","author":"NB Eijsvoogel","year":"2017","unstructured":"Eijsvoogel NB et al (2017) Declining antibody levels after hepatitis B vaccination in Down syndrome: a need for booster vaccination? J Med Virol 89(9):1682\u20131685","journal-title":"J Med Virol"},{"issue":"12","key":"7364_CR18","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/INF.0b013e3182737410","volume":"31","author":"MA Kusters","year":"2012","unstructured":"Kusters MA et al (2012) Influenza A\/H1N1 vaccination response is inadequate in Down syndrome children when the latest cut-off values are used. Pediatr Infect Dis J 31(12):1284\u20131285","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"7364_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/j.1536-4801.2004.tb00863.x","volume":"39","author":"CT Ferreira","year":"2004","unstructured":"Ferreira CT et al (2004) Immunogenicity and safety of an inactivated hepatitis A vaccine in children with Down syndrome. J Pediatr Gastroenterol Nutr 39(4):337\u2013340","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"7364_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02496","volume":"10","author":"LMA Janssen","year":"2019","unstructured":"Janssen LMA et al (2019) Focusing on good responders to pneumococcal polysaccharide vaccination in general hospital patients suspected for immunodeficiency. A decision tree based on the 23-valent pneumococcal IgG assay. Front Immunol 10:2496","journal-title":"Front Immunol"},{"issue":"4","key":"7364_CR21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/cid\/ciz226","volume":"70","author":"M van Aalst","year":"2019","unstructured":"van Aalst M et al (2019) Immunogenicity of the currently recommended pneumococcal vaccination schedule in patients with inflammatory bowel disease. Clin Infect Dis 70(4):595\u2013604","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7364_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/cei.12299","volume":"177","author":"DA van Kessel","year":"2014","unstructured":"van Kessel DA et al (2014) Response to pneumococcal vaccination in mannose-binding lectin-deficient adults with recurrent respiratory tract infections. Clin Exp Immunol 177(1):272\u2013279","journal-title":"Clin Exp Immunol"},{"key":"7364_CR23","doi-asserted-by":"publisher","unstructured":"Huggard D, Doherty DG, Molloy EJ (2020), Immune dysregulation in children with Down syndrome. Front\u00a0Pediatr 8:73. https:\/\/doi.org\/10.3389\/fped.2020.00073","DOI":"10.3389\/fped.2020.00073"},{"issue":"Suppl 2","key":"7364_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2249.2011.04388.x","volume":"164","author":"C Cunningham-Rundles","year":"2011","unstructured":"Cunningham-Rundles C (2011) Autoimmunity in primary immune deficiency: taking lessons from our patients. Clin Exp Immunol 164(Suppl 2):6\u201311","journal-title":"Clin Exp Immunol"},{"key":"7364_CR25","volume":"27","author":"A Musolino","year":"2025","unstructured":"Musolino A et al (2025) Antibody response after pneumococcal vaccination in a large cohort of Italian children and adolescents with Down syndrome. Vaccine: X 27:100744","journal-title":"Vaccine: X"},{"issue":"2","key":"7364_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001035","volume":"5","author":"C Rondaan","year":"2019","unstructured":"Rondaan C et al (2019) Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations. RMD Open 5(2):e001035","journal-title":"RMD Open"},{"issue":"9","key":"7364_CR27","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1080\/21645515.2015.1009337","volume":"11","author":"Y Liang","year":"2015","unstructured":"Liang Y et al (2015) A literature review on the patients with autoimmune diseases following vaccination against infections. Hum Vaccin Immunother 11(9):2274\u20132280","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"7364_CR28","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00431-010-1253-0","volume":"169","author":"ME Weijerman","year":"2010","unstructured":"Weijerman ME, de Winter JP (2010) Clinical practice. The care of children with Down syndrome. Eur J Pediatr 169(12):1445\u201352","journal-title":"Eur J Pediatr"},{"key":"7364_CR29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-057010","author":"MJ Bull","year":"2022","unstructured":"Bull MJ et al (2022) Health supervision for children and adolescents with Down syndrome. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2022-057010","journal-title":"Pediatrics"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07364-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07364-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07364-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:54:33Z","timestamp":1789181673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07364-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["7364"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07364-w","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki. Ethical approval was obtained from the Ethics Committee METC Brabant (reference number NW2020-04).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants or their legal guardians.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"699"}}